mipomersen News
Most Popular mipomersen Story
Genzyme, Isis solidify collaboration agreement
Genzyme Corp. and Isis Pharmaceuticals Inc. completed their agreement for the cholesterol drug candidate, mipomersen. The two companies have been developing an agreement to work together and... Read more...
Latest Headlines
- June 25, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
